Combined magnetic resonance imaging and spectroscopic imaging approach to molecular imaging of prostate cancer
Top Cited Papers
Open Access
- 25 September 2002
- journal article
- review article
- Published by Wiley in Journal of Magnetic Resonance Imaging
- Vol. 16 (4) , 451-463
- https://doi.org/10.1002/jmri.10172
Abstract
Magnetic resonance spectroscopic imaging (MRSI) provides a noninvasive method of detecting small molecular markers (historically the metabolites choline and citrate) within the cytosol and extracellular spaces of the prostate, and is performed in conjunction with high‐resolution anatomic imaging. Recent studies in pre‐prostatectomy patients have indicated that the metabolic information provided by MRSI combined with the anatomical information provided by MRI can significantly improve the assessment of cancer location and extent within the prostate, extracapsular spread, and cancer aggressiveness. Additionally, pre‐ and post‐therapy studies have demonstrated the potential of MRI/MRSI to provide a direct measure of the presence and spatial extent of prostate cancer after therapy, a measure of the time course of response, and information concerning the mechanism of therapeutic response. In addition to detecting metabolic biomarkers of disease behavior and therapeutic response, MRI/MRSI guidance can improve tissue selection for ex vivo analysis. High‐resolution magic angle spinning (1H HR‐MAS) spectroscopy provides a full chemical analysis of MRI/MRSI‐targeted tissues prior to pathologic and immunohistochemical analyses of the same tissue. Preliminary 1H HR‐MAS spectroscopy studies have already identified unique spectral patterns for healthy glandular and stromal tissues and prostate cancer, determined the composition of the composite in vivo choline peak, and identified the polyamine spermine as a new metabolic marker of prostate cancer. The addition of imaging sequences that provide other functional information within the same exam (dynamic contrast uptake imaging and diffusion‐weighted imaging) have also demonstrated the potential to further increase the accuracy of prostate cancer detection and characterization. J. Magn. Reson. Imaging 2002;16:451–463.Keywords
This publication has 109 references indexed in Scilit:
- ERA SPECIFIC BIOCHEMICAL RECURRENCE-FREE SURVIVAL FOLLOWING RADICAL PROSTATECTOMY FOR CLINICALLY LOCALIZED PROSTATE CANCERJournal of Urology, 2001
- Inhibitory effect of zinc on human prostatic carcinoma cell growthThe Prostate, 1999
- Immunohistochemical analysis of Ki‐67 antigen and Bcl‐2 protein expression in prostate cancer: effect of neoadjuvant hormonal therapyBritish Journal of Urology, 1998
- Improved water and lipid suppression for 3D PRESS CSI using rf band selective inversion with gradient dephasing (basing)Magnetic Resonance in Medicine, 1997
- Prostate volumes defined by magnetic resonance imaging and computerized tomographic scans for three-dimensional conformal radiotherapyInternational Journal of Radiation Oncology*Biology*Physics, 1996
- Phosphatidylcholine breakdown and signal transductionBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1994
- Phosphorus metabolite characterization of human prostatic adenocarcinoma in a nude mouse model by31P magnetic resonance spectroscopy and high pressure liquid chromatographyNMR in Biomedicine, 1992
- Chemoprevention of prostate cancer: Guidelines for possible intervention strategiesJournal of Cellular Biochemistry, 1992
- Concepts of citrate production and secretion by prostate: 2. Hormonal relationships in normal and neoplastic prostateThe Prostate, 1991
- Modulations of glycerophosphorylcholine and phosphorylcholine in Friend erythroleukemia cells upon in vitro‐induced erythroid differentiation: a31P NMR studyFEBS Letters, 1984